| Preexposure prophylaxis for HIV infection integrated with municipal-and community-based sexual health services AY Liu, SE Cohen, E Vittinghoff, PL Anderson, S Doblecki-Lewis, O Bacon, ... JAMA internal medicine 176 (1), 75-84, 2016 | 654 | 2016 |
| High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project SE Cohen, E Vittinghoff, O Bacon, S Doblecki-Lewis, BS Postle, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 68 (4), 439-448, 2015 | 221 | 2015 |
| Effect of subcutaneous casirivimab and imdevimab antibody combination vs placebo on development of symptomatic COVID-19 in early asymptomatic SARS-CoV-2 infection: a randomized … MP O’Brien, E Forleo-Neto, N Sarkar, F Isa, P Hou, KC Chan, BJ Musser, ... Jama 327 (5), 432-441, 2022 | 98 | 2022 |
| Incidence of venous thromboembolism in transgender women receiving oral estradiol JD Arnold, EP Sarkodie, ME Coleman, DA Goldstein The Journal of Sexual Medicine 13 (11), 1773-1777, 2016 | 76 | 2016 |
| Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results … O Ogbuagu, PJ Ruane, D Podzamczer, LC Salazar, K Henry, DM Asmuth, ... The Lancet HIV 8 (7), e397-e407, 2021 | 67 | 2021 |
| Changes in kidney function associated with daily tenofovir disoproxil fumarate/emtricitabine for HIV preexposure prophylaxis use in the United States demonstration project EC Tang, E Vittinghoff, PL Anderson, SE Cohen, S Doblecki-Lewis, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 77 (2), 193-198, 2018 | 44 | 2018 |
| The preexposure prophylaxis revolution: from clinical trials to routine practice: implementation view from the USA R Elion, M Coleman Current Opinion in HIV and AIDS 11 (1), 67-73, 2016 | 34 | 2016 |
| Patterns and correlates of participant retention in a multi-city pre-exposure prophylaxis demonstration project S Doblecki-Lewis, AY Liu, DJ Feaster, SE Cohen, R Elion, O Bacon, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 79 (1), 62-69, 2018 | 27 | 2018 |
| Integrating HIV pre-exposure prophylaxis into family planning care: a RE-AIM framework evaluation AR Brant, P Dhillon, S Hull, M Coleman, PP Ye, PS Lotke, J Folan, ... AIDS patient care and STDs 34 (6), 259-266, 2020 | 26 | 2020 |
| Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV preexposure prophylaxis EC Tang, E Vittinghoff, SS Philip, S Doblecki-Lewis, O Bacon, W Chege, ... Aids 34 (8), 1181-1186, 2020 | 24 | 2020 |
| Brief report: short-term adherence marker to PrEP predicts future nonretention in a large PrEP demo project: implications for point-of-care adherence testing MA Spinelli, DV Glidden, PL Anderson, M Gandhi, S Cohen, E Vittinghoff, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 81 (2), 158-162, 2019 | 20 | 2019 |
| The risk of family violence after incarceration: An integrative review R Stansfield, D Semenza, L Napolitano, M Gaston, M Coleman, M Diaz Trauma, Violence, & Abuse 23 (2), 476-489, 2022 | 16 | 2022 |
| Out‐of‐pocket costs and HIV pre‐exposure prophylaxis persistence in a US multicity demonstration project NW Furukawa, JA Schneider, ME Coleman, JB Wiener, RK Shrestha, ... Health Services Research 55 (4), 524-530, 2020 | 11 | 2020 |
| International microsurgery club: an effective online collaboration system ETH Tang, M Goh, R Goh, SM Ghoraba, M Shafarenko, PT Hung, ... Journal of Reconstructive Microsurgery 36 (06), 412-419, 2020 | 9 | 2020 |
| Factors associated with intention to initiate pre-exposure prophylaxis in cisgender women at high behavioral risk for HIV in Washington, DC RK Scott, SJ Hull, JC Huang, M Coleman, P Ye, P Lotke, J Beverley, ... Archives of sexual behavior 51 (5), 2613-2624, 2022 | 5 | 2022 |
| Adherence to daily oral TDF/FTC for PrEP in community health center populations: the Sustainable Health Center Implementation PrEP Pilot (SHIPP) study DK Smith, MK Rawlings, N Glick, L Mena, M Coleman, M Houlberg, ... AIDS and Behavior, 1-11, 2022 | 5 | 2022 |
| HIV testing in the US PrEP demonstration project: rEIA vs antigen/antibody vs RNA O Bacon, E Vittinghoff, S Cohen, S Doblecki-Lewis, M Coleman, ... Conference on Retroviruses and Opportunistic Infections, 2016 | 5 | 2016 |
| Understanding psychosocial determinants of PrEP uptake among cisgender women experiencing heightened HIV risk: Implications for multi-level communication intervention SJ Hull, X Duan, AR Brant, P Peng Ye, PS Lotke, JC Huang, ME Coleman, ... Health communication 38 (14), 3264-3275, 2023 | 4 | 2023 |
| Integrated pharmacy and PrEP navigation services to support PrEP uptake: a quality improvement project M Coleman, A Hodges, S Henn, CC Lambert Journal of the Association of Nurses in AIDS Care 31 (6), 685-692, 2020 | 4 | 2020 |
| Authors' reply: race and the public health impact potential of pre-exposure prophylaxis in the United States SE Cohen, E Vittinghoff, S Doblecki-Lewis, M Coleman, O Bacon, R Elion, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 70 (1), e33-e35, 2015 | 4 | 2015 |
